The global bone growth stimulation market was valued at $400 million in 2024 and is projected to grow at a CAGR of 3.1%, reaching approximately $495 million by 2031.
Growth is fueled by:
- A rise in bone healing procedures and non-union fractures
- Technological developments in portable, patient-friendly devices
- Increasing awareness of non-invasive alternatives to surgical intervention
- The full report suite includes:
- Electrical Bone Growth Stimulators
- Ultrasound Bone Growth Stimulators
Market Report Data Types Included
- Unit Sales & Average Selling Prices (ASP)
- Market Size & Growth Trends
- Market Forecasts to 2031
- Historical Data (2021-2024)
- Market Drivers & Limiters
- Mergers & Acquisitions
- Competitor Profiles & Product Portfolios
Global Bone Growth Stimulation Market Trends
- The key trend is a strong industry shift toward user-friendly devices that enhance patient compliance, which is essential to the efficacy of these treatments
- Companies are investing in ease-of-use designs to improve adherence and clinical outcomes
- A growing number of devices now feature remote monitoring capabilities to boost engagement and results
Market Share Insights (2024)
- 1 Bioventus - Market Leader
- Leads the global market through its Exogen(R) ultrasound bone healing system
- Dominates the ultrasound stimulation segment
- Strong market share in North America, Western Europe, and a growing presence globally
- 2 ZimVie / Highridge Medical - Second Leading Competitor
- Offers the OsteoGen(R) internal bone growth stimulator
- The only notable internal stimulation system on the market
- Maintains a steady global presence and is expected to retain its position
- 3 Orthofix - Third Leading Competitor
- Known for the PhysioStim(TM) external stimulator
- Well-positioned to expand market share as innovation in device design continues
- Gaining attention in markets focused on external, non-invasive therapies
Market Segmentation Summary
- Ultrasound Bone Growth Stimulator Market
- Electrical Bone Growth Stimulator Market
Research Scope Summary
- Regions Covered
- North America: Canada, United States
- Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
- Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
- Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
- Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
- Asia Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
- Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
- Base Year: 2023
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Data Coverage
- Market Size & Forecasts
- Market Growth Rates
- Unit Sales
- Average Selling Prices (ASP)
- Market Shares
Qualitative Data Coverage
- Growth Drivers & Market Limiters
- SWOT Analysis of Key Competitors
- Product Portfolios & Company Profiles
- Mergers & Acquisitions
- FDA Recalls & Disruptive Technology Analysis
- Bone Healing & Related Disease Overviews
Data Sources
- Primary Interviews with Industry Experts
- Government & Physician Records
- Regulatory Filings
- Hospital Procurement Databases
- Import/Export Records
- Internal Database by iData Research